Open AccessThe Impact of a 9-Valent Pneumococcal Conjugate Vaccine on the Public Health Burden of Pneumonia in HIV-Infected and -Uninfected Children
Author(s) -
Shabir A. Madhi,
Locadiah Kuwanda,
Clare Cutland,
Keith P. Klugman
Publication year - 2005
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/429828
Subject(s) - medicine , pneumonia , pneumococcal conjugate vaccine , pneumococcal pneumonia , human immunodeficiency virus (hiv) , streptococcus pneumoniae , intensive care medicine , immunology , virology , pediatrics , microbiology and biotechnology , antibiotics , biology
Pneumococcal conjugate vaccine (PnCV) may be used as a probe to define the burden of pneumococcal disease and better characterize the clinical presentation of pneumococcal pneumonia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom